Fact Sheets | Drug-Resistant TB | Multidrug-Resistant …
Demonstration projects of community-based treatment of drug-resistant TB and integration of TB and HIV care provide opportunities to decentralize management of drug-resistant TB. Summary: Multidrug-resistant and extensively drug-resistant TB disproportionately affect HIV patients and result in increased morbidity and mortality. In this study, we address these.
The continuing spread of drug-resistant tuberculosis (TB) is one of the most urgent and difficult challenges facing global TB control. Patients who are infected with strains resistant to isoniazid and rifampicin, called multidrug-resistant (MDR) TB, are practically incurable by.
4/27/2015 · The continuing spread of drug-resistant tuberculosis (TB) is one of the most urgent and difficult challenges facing global TB control. Patients who are infected with strains resistant to isoniazid and rifampicin, called multidrug-resistant (MDR) TB, are practically incurable by standard first-line treatment.
Multidrug and extensively drug-resistant tuberculosis. The emergence of drug-resistant tuberculosis (TB) compromises global tuberculosis control. The incidence of multidrug-resistant strains (MDR) defined as resistant to the two main antituberculosis drugs, rifampicin and isoniazid, was raised in the 1990s.
Extensively drug-resistant (XDR TB), defined as MDR TB and resistance to the fluoroquinolones and one of the three injectable second-line agents (amikacin, kanamycin or capreomycin), now poses an even graver threat. Initially reported in 2006, XDR TB has now been detected in more than 45 countries [5•,6•] (see Fig. 1).
5/22/2010 · The past 20 years have seen the worldwide appearance of multidrug-resistant (MDR) tuberculosis,2, 3, 4, 5 followed by extensively drug-resistant (XDR) tuberculosis,6, 7, 8, 9 and , most recently, strains that are resistant to all antituberculosis drugs.10 , 11, 12 MDR tuberculosis is caused by Mycobacterium tuberculosis that is resistant at least to isoniazid and rifampicin, and XDR .
2/1/2017 · Abstract. The emergence of drug-resistant tuberculosis (TB) compromises global tuberculosis control. The incidence of multidrug-resistant strains (MDR) defined as resistant to the two main antituberculosis drugs , rifampicin and isoniazid, was raised in the 1990s. Ten percent of these strains have developed additional resistance to the main …
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Although progress has been made to reduce global incidence of drug-susceptible tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis during the past decade threatens to undermine these …
12/1/2007 · Multidrug-resistant and extensively drug-resistant tuberculosis : implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. Andrews JR(1), Shah NS, Gandhi N, Moll T, Friedland G Tugela Ferry Care and Research (TF CARES) Collaboration.
